Tumor-derived EVs are also capable of inducing the expression of PD-L1 on monocytes, via transfer of tumor-cell specific noncoding RNAs, to facilitate immune escape accompanied by concurrent release of cytokines that contribute to cancer-related inflammation [72]. The gene discussed is CD274; the disease is cancer.